Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 143

1.

Maternal immunisation with trivalent inactivated influenza vaccine for prevention of influenza in infants in Mali: a prospective, active-controlled, observer-blind, randomised phase 4 trial.

Tapia MD, Sow SO, Tamboura B, Tégueté I, Pasetti MF, Kodio M, Onwuchekwa U, Tennant SM, Blackwelder WC, Coulibaly F, Traoré A, Keita AM, Haidara FC, Diallo F, Doumbia M, Sanogo D, DeMatt E, Schluterman NH, Buchwald A, Kotloff KL, Chen WH, Orenstein EW, Orenstein LA, Villanueva J, Bresee J, Treanor J, Levine MM.

Lancet Infect Dis. 2016 May 31. pii: S1473-3099(16)30054-8. doi: 10.1016/S1473-3099(16)30054-8. [Epub ahead of print]

2.

The Burden of Cryptosporidium Diarrheal Disease among Children < 24 Months of Age in Moderate/High Mortality Regions of Sub-Saharan Africa and South Asia, Utilizing Data from the Global Enteric Multicenter Study (GEMS).

Sow SO, Muhsen K, Nasrin D, Blackwelder WC, Wu Y, Farag TH, Panchalingam S, Sur D, Zaidi AK, Faruque AS, Saha D, Adegbola R, Alonso PL, Breiman RF, Bassat Q, Tamboura B, Sanogo D, Onwuchekwa U, Manna B, Ramamurthy T, Kanungo S, Ahmed S, Qureshi S, Quadri F, Hossain A, Das SK, Antonio M, Hossain MJ, Mandomando I, Nhampossa T, Acácio S, Omore R, Oundo JO, Ochieng JB, Mintz ED, O'Reilly CE, Berkeley LY, Livio S, Tennant SM, Sommerfelt H, Nataro JP, Ziv-Baran T, Robins-Browne RM, Mishcherkin V, Zhang J, Liu J, Houpt ER, Kotloff KL, Levine MM.

PLoS Negl Trop Dis. 2016 May 24;10(5):e0004729. doi: 10.1371/journal.pntd.0004729. eCollection 2016 May.

3.

Sanitation and Hygiene-Specific Risk Factors for Moderate-to-Severe Diarrhea in Young Children in the Global Enteric Multicenter Study, 2007-2011: Case-Control Study.

Baker KK, O'Reilly CE, Levine MM, Kotloff KL, Nataro JP, Ayers TL, Farag TH, Nasrin D, Blackwelder WC, Wu Y, Alonso PL, Breiman RF, Omore R, Faruque AS, Das SK, Ahmed S, Saha D, Sow SO, Sur D, Zaidi AK, Quadri F, Mintz ED.

PLoS Med. 2016 May 3;13(5):e1002010. doi: 10.1371/journal.pmed.1002010. eCollection 2016 May.

4.

Objection to chronic disease based restrictions during the Hajj.

Memish ZA, Elachola H, Rahman M, Sow S, Aljerian N, Assiri A.

Lancet. 2016 Apr 23;387(10029):1719. doi: 10.1016/S0140-6736(16)30257-4. No abstract available.

PMID:
27116275
5.

Pharyngeal carriage of Neisseria species in the African meningitis belt.

Diallo K, Trotter C, Timbine Y, Tamboura B, Sow SO, Issaka B, Dano ID, Collard JM, Dieng M, Diallo A, Mihret A, Ali OA, Aseffa A, Quaye SL, Bugri A, Osei I, Gamougam K, Mbainadji L, Daugla DM, Gadzama G, Sambo ZB, Omotara BA, Bennett JS, Rebbetts LS, Watkins ER, Nascimento M, Woukeu A, Manigart O, Borrow R, Stuart JM, Greenwood BM, Maiden MC.

J Infect. 2016 Jun;72(6):667-77. doi: 10.1016/j.jinf.2016.03.010. Epub 2016 Mar 23.

6.

Immunization Coverage Surveys and Linked Biomarker Serosurveys in Three Regions in Ethiopia.

Travassos MA, Beyene B, Adam Z, Campbell JD, Mulholland N, Diarra SS, Kassa T, Oot L, Sequeira J, Reymann M, Blackwelder WC, Wu Y, Ruslanova I, Goswami J, Sow SO, Pasetti MF, Steinglass R, Kebede A, Levine MM.

PLoS One. 2016 Mar 2;11(3):e0149970. doi: 10.1371/journal.pone.0149970. eCollection 2016.

7.

Rationale and design of the African group A streptococcal infection registry: the AFROStrep study.

Barth DD, Engel ME, Whitelaw A, Alemseged A, Sadoh WE, Ali SK, Sow SO, Dale J, Mayosi BM.

BMJ Open. 2016 Feb 25;6(2):e010248. doi: 10.1136/bmjopen-2015-010248. Erratum in: BMJ Open. 2016;6(5):e010248corr1.

8.

A Seroepidemiological Study of Serogroup A Meningococcal Infection in the African Meningitis Belt.

Manigart O, Trotter C, Findlow H, Assefa A, Mihret W, Moti Demisse T, Yeshitela B, Osei I, Hodgson A, Quaye SL, Sow S, Coulibaly M, Diallo K, Traore A, Collard JM, Moustapha Boukary R, Djermakoye O, Mahamane AE, Jusot JF, Sokhna C, Alavo S, Doucoure S, Ba el H, Dieng M, Diallo A, Daugla DM, Omotara B, Chandramohan D, Hassan-King M, Nascimento M, Woukeu A, Borrow R, Stuart JM, Greenwood B.

PLoS One. 2016 Feb 12;11(2):e0147928. doi: 10.1371/journal.pone.0147928. eCollection 2016.

9.

Enhanced Diagnosis of Pneumococcal Bacteremia Using Antigen- and Molecular-Based Tools on Blood Specimens in Mali and Thailand: A Prospective Surveillance Study.

Moïsi JC, Moore M, Carvalho Mda G, Sow SO, Siludjai D, Knoll MD, Tapia M, Baggett HC; Laboratory Evaluation of Assays for Pneumococcus (LEAP) Study Investigators.

Am J Trop Med Hyg. 2016 Feb;94(2):267-75. doi: 10.4269/ajtmh.15-0431. Epub 2015 Dec 7.

10.

Immunogenicity of Yellow Fever Vaccine Coadministered With MenAfriVac in Healthy Infants in Ghana and Mali.

Roy Chowdhury P, Meier C, Laraway H, Tang Y, Hodgson A, Sow SO, Enwere GC, Plikaytis BD, Kulkarni PS, Preziosi MP, Niedrig M.

Clin Infect Dis. 2015 Nov 15;61 Suppl 5:S586-93. doi: 10.1093/cid/civ603.

11.

Higher Tetanus Toxoid Immunity 2 Years After PsA-TT Introduction in Mali.

Basta NE, Borrow R, Berthe A, Onwuchekwa U, Dembélé AT, Almond R, Frankland S, Patel S, Wood D, Nascimento M, Manigart O, Trotter CL, Greenwood B, Sow SO.

Clin Infect Dis. 2015 Nov 15;61 Suppl 5:S578-85. doi: 10.1093/cid/civ513.

12.

Neisseria meningitidis Group A IgG1 and IgG2 Subclass Immune Response in African Children Aged 12-23 Months Following Meningococcal Vaccination.

Holme D, Findlow H, Sow SO, Idoko OT, Preziosi MP, Carlone G, Plikaytis BD, Borrow R.

Clin Infect Dis. 2015 Nov 15;61 Suppl 5:S563-9. doi: 10.1093/cid/civ505.

13.

Human Complement Bactericidal Responses to a Group A Meningococcal Conjugate Vaccine in Africans and Comparison to Responses Measured by 2 Other Group A Immunoassays.

Price GA, Hollander AM, Plikaytis BD, Mocca BT, Carlone G, Findlow H, Borrow R, Sow SO, Diallo A, Idoko OT, Enwere GC, Elie C, Preziosi MP, Kulkarni PS, Bash MC.

Clin Infect Dis. 2015 Nov 15;61 Suppl 5:S554-62. doi: 10.1093/cid/civ504.

PMID:
26553688
14.

Population-Level Persistence of Immunity 2 Years After the PsA-TT Mass-Vaccination Campaign in Mali.

Basta NE, Borrow R, Berthe A, Dembélé AT, Onwuchekwa U, Townsend K, Boukary RM, Mabey L, Findlow H, Bai X, Sow SO.

Clin Infect Dis. 2015 Nov 15;61 Suppl 5:S547-53. doi: 10.1093/cid/civ602.

15.

Antibody Persistence at 1 and 4 Years Following a Single Dose of MenAfriVac or Quadrivalent Polysaccharide Vaccine in Healthy Subjects Aged 2-29 Years.

Diallo A, Sow SO, Idoko OT, Hirve S, Findlow H, Preziosi MP, Elie C, Kulkarni PS, Parulekar V, Diarra B, Cheick Haidara F, Diallo F, Tapia M, Akinsola AK, Adegbola RA, Bavdekar A, Juvekar S, Chaumont J, Martellet L, Marchetti E, LaForce MF, Plikaytis BD, Enwere GC, Tang Y, Borrow R, Carlone G, Viviani S.

Clin Infect Dis. 2015 Nov 15;61 Suppl 5:S521-30. doi: 10.1093/cid/civ518.

16.

Antibody Persistence 1-5 Years Following Vaccination With MenAfriVac in African Children Vaccinated at 12-23 Months of Age.

Tapia MD, Findlow H, Idoko OT, Preziosi MP, Kulkarni PS, Enwere GC, Elie C, Parulekar V, Sow SO, Haidara FC, Diallo F, Doumbia M, Akinsola AK, Adegbola RA, Kampmann B, Chaumont J, Martellet L, Marchetti E, Viviani S, Tang Y, Plikaytis BD, LaForce FM, Carlone G, Borrow R.

Clin Infect Dis. 2015 Nov 15;61 Suppl 5:S514-20. doi: 10.1093/cid/civ672.

17.

A Phase 3, Double-Blind, Randomized, Active Controlled Study to Evaluate the Safety of MenAfriVac in Healthy Malians.

Tapia MD, Sow SO, Haidara FC, Diallo F, Doumbia M, Enwere GC, Paranjape G, Hervé J, Bouma E, Parulekar V, Martellet L, Chaumont J, Plikaytis BD, Tang Y, Kulkarni PS, Hartmann K, Preziosi MP.

Clin Infect Dis. 2015 Nov 15;61 Suppl 5:S507-13. doi: 10.1093/cid/civ626.

18.

Active Surveillance for Adverse Events After a Mass Vaccination Campaign With a Group A Meningococcal Conjugate Vaccine (PsA-TT) in Mali.

Vannice KS, Keita M, Sow SO, Durbin AP, Omer SB, Moulton LH, Yaméogo TM, Zuber PL, Onwuchekwa U, Sacko M, Diomandé FV, Halsey NA.

Clin Infect Dis. 2015 Nov 15;61 Suppl 5:S493-500. doi: 10.1093/cid/civ497.

19.

Lessons Learned From Enhancing Vaccine Pharmacovigilance Activities During PsA-TT Introduction in African Countries, 2010-2013.

Diomandé FV, Yaméogo TM, Vannice KS, Preziosi MP, Viviani S, Ouandaogo CR, Keita M, Djingarey MH, Mbakuliyemo N, Akanmori BD, Sow SO, Zuber PL.

Clin Infect Dis. 2015 Nov 15;61 Suppl 5:S459-66. doi: 10.1093/cid/civ599.

20.

Ethical Challenges and Lessons Learned During the Clinical Development of a Group A Meningococcal Conjugate Vaccine.

Martellet L, Sow SO, Diallo A, Hodgson A, Kampmann B, Hirve S, Tapia M, Haidara FC, Ndiaye A, Diarra B, Ansah PO, Akinsola A, Idoko OT, Adegbola RA, Bavdekar A, Juvekar S, Viviani S, Enwere GC, Marchetti E, Chaumont J, Makadi MF, Pallardy F, Kulkarni PS, Preziosi MP, LaForce FM.

Clin Infect Dis. 2015 Nov 15;61 Suppl 5:S422-7. doi: 10.1093/cid/civ598.

Items per page

Supplemental Content

Write to the Help Desk